Are We Focusing on the Right Fish Oil in IBD?
Op Ed: EPA, not just ‘omega-3’, may hold the key to reducing disease risk. For years, dietary advice for people living with…
Read the evidenceRigorous clinical research only matters when it reaches the patient. Vance Medical translates peer-reviewed science and real-world data into practical protocols that clinicians and patients can act on.
Every recommendation we publish is anchored in at least one of these evidence streams and graded against internationally-recognised quality criteria.
Randomised controlled trials and phase II–IV studies investigating medical food and nutritional interventions in IBD, SIBO, and related GI conditions.
Longitudinal outcomes from registered patient cohorts, post-market surveillance, and anonymised dashboard analytics across thousands of IBD journeys.
Curated meta-analyses and systematic reviews from Gut, AJG, Lancet Gastro, JCN, and other indexed journals — summarised for bedside use.
Multidisciplinary panel statements from gastroenterologists, dietitians, and pharmacists who have validated the protocol pathways we publish.
The journey every piece of evidence takes before it reaches a clinician protocol or a patient-facing recommendation.
Our medical writing team combines primary studies, guidelines, and registry data into a single graded position — with conflicts of interest and limitations flagged openly.
We convert each position into two companion artefacts: a clinician-facing protocol card and a plain-language patient brief vetted by a patient advisory panel.
Protocols feed the Vance Medical dashboard, the Ask AI assistant, and downloadable handouts — so evidence becomes a concrete decision at the point of care.
Recent reviews, trial readouts, and protocol updates published by the Vance Medical editorial team.
Free registration unlocks the full protocol library, the Ask AI clinical assistant, and printable patient handouts branded to your practice.